<?xml version="1.0" encoding="UTF-8"?>

<rootTag>
  <Award>
    <AwardTitle>STTR Phase II: Engineering Clostridial Fermentation for Biobutanol Production</AwardTitle>
    <AwardEffectiveDate>08/15/2010</AwardEffectiveDate>
    <AwardExpirationDate>01/31/2013</AwardExpirationDate>
    <AwardAmount>512000</AwardAmount>
    <AwardInstrument>
      <Value>Standard Grant</Value>
    </AwardInstrument>
    <Organization>
      <Code>07070000</Code>
      <Directorate>
        <LongName>Directorate for Engineering</LongName>
      </Directorate>
      <Division>
        <LongName>Division of Industrial Innovation and Partnerships</LongName>
      </Division>
    </Organization>
    <ProgramOfficer>
      <SignBlockName>Ruth M. Shuman</SignBlockName>
    </ProgramOfficer>
    <AbstractNarration>This STTR Phase II project will develop novel engineered Clostridia strains for fermentation and economically produce butanol as a biofuel from sugars derived from starchy and lignocellulosic biomass. The conventional acetone-butanol-ethanol (ABE)&lt;br/&gt;fermentation has low butanol yield (&lt;25%), butanol concentration (&lt;16 g/L), and reactor productivity (&lt;0.5 g/L?h) due to a strong butanol inhibition, and the fermentation process is difficult to improve due to the complicated metabolic pathways and gene regulation involved in the production microorganisms, mainly Clostridium acetobutylicum.&lt;br/&gt;&lt;br/&gt;The broader impact/commercial potential of the project is to produce butanol as a biofuel from sugars derived from starchy and lignocellulosic biomass. Biobutanol has great value as an alternative transportation fuel. There is a huge potential commercial and societal impact in improving yields and reducing costs of butanol production. The research and other activity proposed could lead directly to a marketable product and process and leads to several enabling technologies, including better manipulation of C. tyrobutylicum, further demonstration of strain improvements using the FBB, and others.</AbstractNarration>
    <MinAmdLetterDate>08/02/2010</MinAmdLetterDate>
    <MaxAmdLetterDate>07/14/2012</MaxAmdLetterDate>
    <ARRAAmount/>
    <AwardID>1026648</AwardID>
    <Investigator>
      <FirstName>Shang-Tian</FirstName>
      <LastName>Yang</LastName>
      <EmailAddress>yang.15@osu.edu</EmailAddress>
      <StartDate>08/02/2010</StartDate>
      <EndDate/>
      <RoleCode>Co-Principal Investigator</RoleCode>
    </Investigator>
    <Investigator>
      <FirstName>I-Ching</FirstName>
      <LastName>Tang</LastName>
      <EmailAddress>bictang@sbcglobal.net</EmailAddress>
      <StartDate>08/02/2010</StartDate>
      <EndDate/>
      <RoleCode>Principal Investigator</RoleCode>
    </Investigator>
    <Institution>
      <Name>Bioprocessing Innovative Company, Inc.</Name>
      <CityName>Dublin</CityName>
      <ZipCode>430172599</ZipCode>
      <PhoneNumber>6147611552</PhoneNumber>
      <StreetAddress>4734 Bridal Path Court</StreetAddress>
      <CountryName>United States</CountryName>
      <StateName>Ohio</StateName>
      <StateCode>OH</StateCode>
    </Institution>
  </Award>
</rootTag>
